SRPX2 and RAB31 are effective prognostic biomarkers in pancreatic cancer.

Li, Hao; Zhang, Shi-Rong; Xu, Hua-Xiang; Wang, Wen-Quan; Li, Shuo; Li, Tian-Jiao; Ni, Quan-Xing; Yu, Xian-Jun; Liu, Liang; Wu, Chun-Tao.

Affiliation

Li H; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 20032, China.
Zhang SR; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Xu HX; Shanghai Pancreatic Cancer Institute, Shanghai 200032, China.
Wang WQ; Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China.
Li S; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 20032, China.
Li TJ; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Ni QX; Shanghai Pancreatic Cancer Institute, Shanghai 200032, China.
Yu XJ; Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China.
Liu L; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 20032, China.
Wu CT; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.